נרוסין

Pajjiż: Iżrael

Lingwa: Ebrajk

Sors: Ministry of Health

Ingredjent attiv:

NAPROXEN SODIUM

Disponibbli minn:

TEVA ISRAEL LTD

Kodiċi ATC:

M01AE02

Għamla farmaċewtika:

טבליה

Kompożizzjoni:

NAPROXEN SODIUM 275 MG

Rotta amministrattiva:

פומי

Tip ta 'preskrizzjoni:

אין צורך במרשם

Manifatturat minn:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Żona terapewtika:

NAPROXEN

Data ta 'l-awtorizzazzjoni:

2014-11-30

Fuljett ta 'informazzjoni

Narocin SZ 1.2024 NOTIFICATION
ʥ"ʮʹʺʤ (ʭʩʸʩʹʫʺ) ʭʩʧʷʥʸʤ ʺʥʰʷʺ ʩʴʬ
ʯʫʸʶʬ ʯʥʬʲ
-
986
1
ʤʴʥʸʺʤ
ʺʷʥʥʹʮ
ʠʬʬ
ʠʴʥʸ ʭʹʸʮ
ʯʩʱʥʸʰ
®
ʺʥʩʬʡʨ
ʡʫʸʤ
ʬʫ
ʤʬʩʫʮ ʤʩʬʡʨ
:
ʭʥʩʣʥʱ ʯʱʷʥʸʴʰ
275
) ʢ"ʮ
Naproxen sodium 275 mg
(
ʭʩʡʩʫʸʮ ʬʲ ʲʣʩʮʬ
ʭʩʬʩʲʴ ʩʺʬʡ
ʭʩʰʢʸʬʠʥ
ʤʠʸ
ʡ
ʳʩʲʱ
2
ʷʬʧ ʬʲ ʡʥʹʧ ʲʣʩʮ"
ʥ "ʤʴʥʸʺʤ ʬʹ ʭʩʡʩʫʸʮʤʮ
ʯʫ
ʳʩʲʱ
6
."ʳʱʥʰ ʲʣʩʮ"
.ʤʴʥʸʺʡ ʹʮʺʹʺ ʭʸʨʡ ʥʴʥʱ ʣʲ ʯʥʬʲʤ ʺʠ
ʯʥʩʲʡ ʠʸʷ
ʪʬ ʹʩ ʭʠ .ʤʴʥʸʺʤ ʬʲ ʩʺʩʶʮʺ ʲʣʩʮ ʬʩʫʮ ʤʦ
ʯʥʬʲ
.ʧʷʥʸʤ ʬʠ ʥʠ ʠʴʥʸʤ ʬʠ ʤʰʴ ,ʺʥʴʱʥʰ ʺʥʬʠʹ
ʪʩʬʲ
ʬʥʨʩʬ
ʺʠ
ʸʩʹʫʺʤ
ʬʲ
ʩʴ
ʺʥʠʸʥʤʤ
ʳʩʲʱʡ
ʯʥʰʩʮʤ
ʯʥʬʲʡ
ʤʦ
.
ʵʲʥʥʩʤ
ʧʷʥʸʡ
ʭʠ
ʤ
ʩ
ʪʰ
ʷʥʷʦ
ʲʣʩʮʬ
.ʳʱʥʰ
ʪʩʬʲ
ʺʥʰʴʬ
ʠʴʥʸʬ
ʥ ʤʣʩʮʡ
ʮ ʸʺʥʩ ʪʹʮʰ ʭʥʧʤ
-
3
ʮ ʸʺʥʩ ʭʩʫʹʮʰ ʭʩʡʠʫʤ ʭʠ ʥʠ ʭʩʮʩ
-
10
.ʭʩʮʩ
1
.
ʤʴʥʸʺʤ ʺʣʲʥʩʮ ʤʮʬ
?
ʤʴʥʸʺʤ
ʺʣʲʥʩʮ
ʬ
ʣʲ ʭʩʬʷ ʭʩʡʠʫ ʪʥʫʩʹ
ʭʩʩʰʥʰʩʡ
ʡʢ ʩʡʠʫ ,ʭʩʩʰʩʹ ʩʡʠʫ ʯʥʢʫ
ʩʡʠʫʥ
,ʸʥʦʧʮ
ʬ
,ʭʥʧ ʺʣʸʥʤ
ʺʥʩʨʮʥʠʸ ʺʥʷʬʣʡ ʬʥʴʩʨʬ
ʣʬʹʤ ʩʸʩʸʹʥ ʭʩʣʩʢ ʺʥʷʬʣʡ ʬʥʴʩʨʬ
,(ʺʥʩʰʥʸʢʹ)
.
:ʺʩʨʩʥʴʸʺ ʤʶʥʡʷ
ʺʶʥʡʷʮ ʭʩʡʠʫ ʪʫʹʮ
ʣʢʥʰ
ʩ
ʰʩʠʹ ʺʥʷʬʣ
ʭ
ʩʣʩʠʥʸʨʱ
ʭ
)
NSAIDs
.(
2
.
ʤʴʥʸʺʡ ʹʥʮʩʹʤ ʩʰʴʬ
:ʥʦ ʤʴʥʸʺʡ ʹʮʺʹʤʬ ʯʩʠ
:ʩʢʸʬʠ ʤʺʠʹ ʥʠ ʸʺʩ ʺʥʹʩʢʸ ʪʬ ʹʩ ʭʠ

ʬ
ʯʱʷʥʸʴʰ
,
ʭʥʩʣʥʱ ʯʱʷʥʸʴʰʬ
ʣʧʠ ʬʫʬ ʥʠ
ʮ
ʤʴʥʸʺʤ ʤʬʩʫʮ ʸʹʠ ʭʩʴʱʥʰʤ ʭʩʡʩʫʸʮʤ
)
ʤʠʸ
ʺʮʩʹʸ ʺʠ
ʭʩʡʩʫʸʮʤ
ʡ
ʳʩʲʱ
6
(
.

ʬ
,ʯʩʸʩʴʱʠ
ʬ
ʭʩʡʠʫ ʪʫʹʮ
ʸʧʠ
ʥʠ ʥʤʹʬʫ
ʬ
ʤ ʺʶʥʡʷʮ ʺʸʧʠ ʤʴʥʸʺ
-
NSAIDs
ʮʢʥʣʬ)
ʤ
ʥʠ ʯʴʥʸʴʥʡʩʠ
(ʷʰʴʥʬʷʩʣ
.
ʯʩʠ
�